QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
NASDAQ:BKYI

BIO-key International (BKYI) Stock Forecast, Price & News

$0.55
+0.03 (+5.81%)
(As of 09/27/2023 ET)
Compare
Today's Range
$0.52
$0.55
50-Day Range
$0.48
$0.75
52-Week Range
$0.46
$1.70
Volume
4,429 shs
Average Volume
18,689 shs
Market Capitalization
$5.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BKYI stock logo

About BIO-key International (NASDAQ:BKYI) Stock

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

BKYI Price History

BKYI Stock News Headlines

How A.I. Could Make Most 21st Century Diseases EXTINCT
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
BIO-Key Accepted by Amazon Web Services
Q2 2023 BIO-Key International Inc Earnings Call
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult. And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
BIO-key Intl's Earnings Outlook
Bio-Key Vaults on Iowa Connection
See More Headlines
Receive BKYI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter.

BKYI Company Calendar

Last Earnings
8/14/2023
Today
9/27/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:BKYI
Employees
51
Year Founded
N/A

Profitability

Net Income
$-11,910,000.00
Net Margins
-117.65%
Pretax Margin
-132.35%

Debt

Sales & Book Value

Annual Sales
$7.02 million
Book Value
$0.63 per share

Miscellaneous

Free Float
8,209,000
Market Cap
$5.06 million
Optionable
Not Optionable
Beta
1.05
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Michael W. DePasqualeMr. Michael W. DePasquale (Age 68)
    Chairman & CEO
    Comp: $296.83k
  • Mr. Kwok Fong Wong (Age 60)
    MD of Hong Kong & Vice-Chairman
  • Ms. Mira K. LaCous (Age 61)
    Chief Technology Officer
    Comp: $224.3k
  • Mr. James David SullivanMr. James David Sullivan (Age 56)
    Sr. VP of Strategy & Compliance and Chief Legal Officer
    Comp: $367.49k
  • Ms. Cecilia C. Welch (Age 63)
    Chief Financial Officer
  • Mr. Akintunde Carlton Jeje
    Managing Director of Africa
  • Mr. Alex Rocha
    Managing Director of EMEA
  • Mr. Mark Cochran
    Pres of PortalGuard













BKYI Stock - Frequently Asked Questions

How have BKYI shares performed in 2023?

BIO-key International's stock was trading at $0.5851 at the beginning of the year. Since then, BKYI stock has decreased by 6.7% and is now trading at $0.5461.
View the best growth stocks for 2023 here
.

Are investors shorting BIO-key International?

BIO-key International saw a increase in short interest in September. As of September 15th, there was short interest totaling 18,300 shares, an increase of 195.2% from the August 31st total of 6,200 shares. Based on an average trading volume of 25,100 shares, the days-to-cover ratio is currently 0.7 days. Currently, 0.2% of the company's stock are sold short.
View BIO-key International's Short Interest
.

When is BIO-key International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our BKYI earnings forecast
.

How were BIO-key International's earnings last quarter?

BIO-key International, Inc. (NASDAQ:BKYI) issued its quarterly earnings data on Monday, August, 14th. The technology company reported ($0.16) EPS for the quarter. The technology company earned $1.93 million during the quarter. BIO-key International had a negative net margin of 117.65% and a negative trailing twelve-month return on equity of 122.43%.

What other stocks do shareholders of BIO-key International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BIO-key International investors own include Biocept (BIOC), T2 Biosystems (TTOO), iBio (IBIO), Onconova Therapeutics (ONTX), Acasti Pharma (ACST), Co-Diagnostics (CODX), Heat Biologics (HTBX), Tonix Pharmaceuticals (TNXP), VBI Vaccines (VBIV) and Inovio Pharmaceuticals (INO).

What is BIO-key International's stock symbol?

BIO-key International trades on the NASDAQ under the ticker symbol "BKYI."

How do I buy shares of BIO-key International?

Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BIO-key International's stock price today?

One share of BKYI stock can currently be purchased for approximately $0.55.

How much money does BIO-key International make?

BIO-key International (NASDAQ:BKYI) has a market capitalization of $5.06 million and generates $7.02 million in revenue each year. The technology company earns $-11,910,000.00 in net income (profit) each year or ($1.13) on an earnings per share basis.

How can I contact BIO-key International?

BIO-key International's mailing address is 3349 HIGHWAY 138 BUILDING A SUITE E, WALL NJ, 07719. The official website for the company is www.bio-key.com. The technology company can be reached via phone at (732) 359-1100, via email at bkyi@catalyst-ir.com, or via fax at 732-359-1101.

This page (NASDAQ:BKYI) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -